Trial NCT05131204

View at ClinicalTrials.gov 
Org. Study IDs: R3918-PNH-2022
Secondary IDs: 2020-002761-33

Last trial update was posted on 2023-08-16

MeSH Interventions

Eculizumab Ravulizumab

MeSH Conditions

Hemoglobinuria Hemoglobinuria, Paroxysmal

Other Conditions

Paroxysmal Nocturnal Hemoglobinuria

Stopping Reasons

Sponsor decision not related to efficacy or safety.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID